A detailed history of Fiduciary Alliance LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fiduciary Alliance LLC holds 3,727 shares of LLY stock, worth $2.96 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
3,727
Previous 723 415.49%
Holding current value
$2.96 Million
Previous $656 Million 403.69%
% of portfolio
0.44%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$772.14 - $960.02 $2.32 Million - $2.88 Million
3,004 Added 415.49%
3,727 $3.3 Billion
Q2 2024

Jul 09, 2024

BUY
$724.87 - $909.04 $301,545 - $378,160
416 Added 135.5%
723 $656 Million
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $181,805 - $243,229
307 New
307 $234 Million
Q2 2023

Jul 18, 2023

BUY
$350.74 - $468.98 $97,505 - $130,376
278 New
278 $130 Million
Q4 2022

Jan 19, 2023

BUY
$321.55 - $374.67 $85,532 - $99,662
266 New
266 $97.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $755B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fiduciary Alliance LLC Portfolio

Follow Fiduciary Alliance LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Alliance LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Alliance LLC with notifications on news.